Evidence map›Paper›PMID 37323510›Full record

ArticleSynthetic biology (Oxford, England)2023

Biosynthesis of cannabigerol and cannabigerolic acid: the gateways to further cannabinoid production.

Lewis J Kearsey, Cunyu Yan, Nicole Prandi, Helen S Toogood, Eriko Takano, Nigel S Scrutton

Open access · goldAbstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Synthetic biology (Oxford, England), 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
4.8field-weighted citation impact, top 6% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed, 12 citations in OpenAlex.

  1. Article
  2. Review
  3. Article
  4. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 2 institutions in 2 countries.

Lewis J KearseyManchester Institute of Biotechnology and School of Chemistry, University of Manchester, Manchester M1 7DN, UK.
Cunyu YanBBSRC/EPSRC Synthetic Biology Research Centre SYNBIOCHEM, University of Manchester, Manchester M1 7DN, UK.
Nicole PrandiManchester Institute of Biotechnology and School of Chemistry, University of Manchester.
Helen S ToogoodManchester Institute of Biotechnology and School of Chemistry, University of Manchester, Manchester M1 7DN, UK.
Eriko TakanoManchester Institute of Biotechnology and School of Chemistry, University of Manchester, Manchester M1 7DN, UK.ORCID https://orcid.org/0000-0002-6791-3256
Nigel S ScruttonManchester Institute of Biotechnology and School of Chemistry, University of Manchester, Manchester M1 7DN, UK.ORCID https://orcid.org/0000-0003-4797-0293
Engineering and Physical Sciences Research Council · GBUniversity of Manchester · GB

Funding

Biotechnology and Biological Sciences Research Council BB/M017702/1
6 · The paper itself

Abstract

Cannabinoids are a therapeutically valuable class of secondary metabolites with a vast number of substituents. The native cannabinoid biosynthetic pathway of

Indexed as

aromatic prenyltransferaseCannabigerolcannabigerolic acidEscherichia colisynthetic biology

Identifiers

PMID37323510
PMCPMC10263468
OpenAlexW4378710481

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.